CME

CME

USD

CME Group Inc. Class A Common Stock

$267.850+0.510 (0.191%)

Reaalajas hind

Finantsteenused
Financial Data & Stock Exchanges
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$267.340

Kõrge

$268.480

Madal

$264.160

Maht

1.84M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

96.6B

Tööstusharu

Financial Data & Stock Exchanges

Riik

United States

Kauplemisstatistika

Keskmine maht

1.87M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $213.94Praegune $267.850Kõrge $290.79

Seotud uudised

Analyst Upgrades

UBS Maintains Neutral on CME Group, Lowers Price Target to $280

UBS analyst Alex Kramm maintains CME Group with a Neutral and lowers the price target from $285 to $280.

Vaata rohkem
UBS Maintains Neutral on CME Group, Lowers Price Target to $280
Analyst Upgrades

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $314

Morgan Stanley analyst Patrick Moley maintains CME Group with a Overweight and raises the price target from $312 to $314.

Vaata rohkem
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $314
Analyst Upgrades

Deutsche Bank Upgrades CME Group to Buy, Raises Price Target to $300

Deutsche Bank analyst Brian Bedell upgrades CME Group from Hold to Buy and raises the price target from $266 to $300.

Vaata rohkem
Deutsche Bank Upgrades CME Group to Buy, Raises Price Target to $300
PR Newswire

CME Group Inc. Announces Third-Quarter 2025 Financial Results

CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2025. The company reported revenue of $1.5 billion and...

Vaata rohkem
CME Group Inc. Announces Third-Quarter 2025 Financial Results
Analyst Upgrades

Raymond James Maintains Outperform on CME Group, Lowers Price Target to $307

Raymond James analyst Patrick O'Shaughnessy maintains CME Group with a Outperform and lowers the price target from $309 to $307.

Vaata rohkem
Raymond James Maintains Outperform on CME Group, Lowers Price Target to $307
Analyst Upgrades

Barclays Maintains Equal-Weight on CME Group, Lowers Price Target to $280

Barclays analyst Benjamin Budish maintains CME Group with a Equal-Weight and lowers the price target from $298 to $280.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.